A health economic evaluation of the multinational, randomized controlled CONVINCE trial: cost-utility of high-dose online hemodiafiltration compared to high-flux hemodialysisAniek E.M. Schouten, M. L. Bots, G. Ardine de Wit et al.|Kidney International|2025Cited by 17
Psychosocial Determinants for Self-Reported Health Status in Patients on HemodialysisKrister Cromm, Matthias Rose, Le Hong Ngoc Pham et al.|Kidney360|2024Cited by 3
Cost Utility of High-Dose Online Hemodiafiltration Compared with High-Flux Hemodialysis: Economic Evaluation of the Multinational, Randomized Controlled CONVINCE TrialAniek E.M. Schouten, Miriam P. van der Meulen, Felix Fischer et al.|Journal of the American Society of Nephrology|2024Cited by 0
Patient-Reported Health Status of Adults with Kidney Failure Receiving Hemodiafiltration vs. Hemodialysis: Results from the CONVINCE Randomized Controlled Clinical TrialMatthias Rose, P. J. Blankestijn, Felix Fischer et al.|Journal of the American Society of Nephrology|2023Cited by 0
Characteristics of Populations Included in Randomized Controlled Trials of Hemodiafiltration and Registry Real-Life PopulationsKrister Cromm, Giovanni FM Strippoli, Tom Yuen et al.|Clinical Journal of the American Society of Nephrology|2025Cited by 0